Correlation Between Pieris Pharmaceuticals and Applied Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pieris Pharmaceuticals and Applied Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pieris Pharmaceuticals and Applied Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pieris Pharmaceuticals and Applied Therapeutics, you can compare the effects of market volatilities on Pieris Pharmaceuticals and Applied Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pieris Pharmaceuticals with a short position of Applied Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pieris Pharmaceuticals and Applied Therapeutics.

Diversification Opportunities for Pieris Pharmaceuticals and Applied Therapeutics

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pieris and Applied is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Pieris Pharmaceuticals and Applied Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Applied Therapeutics and Pieris Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pieris Pharmaceuticals are associated (or correlated) with Applied Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Applied Therapeutics has no effect on the direction of Pieris Pharmaceuticals i.e., Pieris Pharmaceuticals and Applied Therapeutics go up and down completely randomly.

Pair Corralation between Pieris Pharmaceuticals and Applied Therapeutics

Given the investment horizon of 90 days Pieris Pharmaceuticals is expected to generate 0.88 times more return on investment than Applied Therapeutics. However, Pieris Pharmaceuticals is 1.14 times less risky than Applied Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Applied Therapeutics is currently generating about -0.01 per unit of risk. If you would invest  1,376  in Pieris Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of  249.00  from holding Pieris Pharmaceuticals or generate 18.1% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Pieris Pharmaceuticals  vs.  Applied Therapeutics

 Performance 
       Timeline  
Pieris Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pieris Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Pieris Pharmaceuticals is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Applied Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Applied Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pieris Pharmaceuticals and Applied Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pieris Pharmaceuticals and Applied Therapeutics

The main advantage of trading using opposite Pieris Pharmaceuticals and Applied Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pieris Pharmaceuticals position performs unexpectedly, Applied Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Applied Therapeutics will offset losses from the drop in Applied Therapeutics' long position.
The idea behind Pieris Pharmaceuticals and Applied Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA